MX9302024A - Epitopes de celula t de los alergenos principales de ambrosina artemisfolia. - Google Patents

Epitopes de celula t de los alergenos principales de ambrosina artemisfolia.

Info

Publication number
MX9302024A
MX9302024A MX9302024A MX9302024A MX9302024A MX 9302024 A MX9302024 A MX 9302024A MX 9302024 A MX9302024 A MX 9302024A MX 9302024 A MX9302024 A MX 9302024A MX 9302024 A MX9302024 A MX 9302024A
Authority
MX
Mexico
Prior art keywords
amb
allergens
artemisfolia
ambrosine
cell epitopes
Prior art date
Application number
MX9302024A
Other languages
English (en)
Inventor
Mei-Chang Kuo
Richard D Garman
Julia L Greenstein
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Publication of MX9302024A publication Critical patent/MX9302024A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención proporciona péptidos aislados de los principales alergenos proteicos de Ambrosia artemisiifolia, o polen de ambrosía corta. Los péptidos dentro del alcance de esta invención comprende por lo menos un epitopo para células, o preferiblemente por lo menos dos epitopos para la célula T de un alergeno proteico seleccionado de los alergenos Amb a I.1, Amb a I.2, Amb a I.3, Amb a I.4 y Amb a II. Se describen péptidos modificados que tienen propiedades terapéuticas similares o mejoradas en comparación con el alergeno o porción del mismo correspondiente, que se presenta de manera natural, pero que tienen efectos laterales reducidos.
MX9302024A 1992-04-09 1993-04-07 Epitopes de celula t de los alergenos principales de ambrosina artemisfolia. MX9302024A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86667992A 1992-04-09 1992-04-09

Publications (1)

Publication Number Publication Date
MX9302024A true MX9302024A (es) 1994-07-29

Family

ID=25348157

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302024A MX9302024A (es) 1992-04-09 1993-04-07 Epitopes de celula t de los alergenos principales de ambrosina artemisfolia.

Country Status (12)

Country Link
EP (2) EP0636180A1 (es)
JP (1) JPH07507924A (es)
KR (1) KR950700991A (es)
AU (1) AU685392B2 (es)
CA (1) CA2117779A1 (es)
FI (1) FI944697A (es)
IL (1) IL105352A0 (es)
MX (1) MX9302024A (es)
NO (1) NO943811L (es)
NZ (1) NZ252013A (es)
WO (1) WO1993021321A2 (es)
ZA (1) ZA932530B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ273815A (en) * 1994-09-02 1999-05-28 Immulogic Pharma Corp Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
AU748104B2 (en) * 1994-09-02 2002-05-30 Merck Patent Gmbh Peptide compositions capable of down regulating an antigen specific immune response
WO1996013589A1 (en) * 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
GB2349463B (en) 1996-03-21 2001-01-10 Circassia Ltd Cryptic peptides and method for their identification
WO2001077353A2 (en) * 2000-04-05 2001-10-18 Syngenta Participations Ag Expression of pollen allergens in plastids
EP1958645A1 (en) * 2007-02-13 2008-08-20 Biomay AG Peptides derived from the major allergen of ragweed (Ambrosia artemisiifolia) and uses thereof
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
EP2153841B2 (en) * 2008-08-15 2015-11-11 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
EP2331124A1 (en) 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
DK2723373T3 (en) * 2011-06-27 2017-09-18 Anergis S A OVERLAPPING ADJUSTING PEPTIDES FOR TREATMENT
WO2017179025A1 (en) * 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011293A1 (en) * 1989-03-17 1990-10-04 Immulogic Pharmaceutical Corporation Allergenic proteins from ragweed and uses therefor

Also Published As

Publication number Publication date
EP0636180A1 (en) 1995-02-01
KR950700991A (ko) 1995-02-20
EP0770681A2 (en) 1997-05-02
FI944697A (fi) 1994-12-07
JPH07507924A (ja) 1995-09-07
AU4046293A (en) 1993-11-18
NO943811L (no) 1994-12-06
AU685392B2 (en) 1998-01-22
ZA932530B (en) 1993-10-28
NO943811D0 (no) 1994-10-07
CA2117779A1 (en) 1993-10-28
WO1993021321A2 (en) 1993-10-28
WO1993021321A3 (en) 1994-02-03
FI944697A0 (fi) 1994-10-07
NZ252013A (en) 1996-08-27
IL105352A0 (en) 1993-08-18
EP0770681A3 (en) 1997-06-04

Similar Documents

Publication Publication Date Title
MX9302024A (es) Epitopes de celula t de los alergenos principales de ambrosina artemisfolia.
FI941757A (fi) Dermatofagoideista (talopölypunkki) peräisin olevien pääallergeenien T-soluepitoopit
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
BR9408063A (pt) Antagonistas de receptores de taquicinina que nÆo sÆo pept¡deos
NO983999L (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
DK1090039T3 (da) Peptidsammensætning som immunogen til behandling af allergi
ATE245977T1 (de) Therapeutische substituierte guanidine
BR0205983A (pt) fármacos peptìdicos antiangiogênicos
IL147766A0 (en) Therapeutic compounds comprised of anti-fc receptor binding agents
DK0610335T3 (da) Fremgangsmåder til udformning af rekombitope peptider
George et al. Oxidized low‐density lipoprotein (Ox‐LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)
PT845998E (pt) Medicamentos para imunoterapia contendo anticorpos que reconhecem de forma especifica o antigenio mhcii de um paciente a ser tratado
MX9301675A (es) Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno.
DK1025849T3 (da) Fremgangsmåder til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-antigener
NO950526L (no) T-celleepitoper av raigresspollen-allergen
ATE406178T1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
SE9703531D0 (sv) Non-anaphlactic forms of allergens and their use
ES2085947T3 (es) Proteinas hibridas protectoras de plasmodium falciparum que contienen secuencias parciales de los antigenos de malaria hrpii y serp.
CA2160121A1 (en) T cell epitopes of the major allergens from dermatophagoides (house dust mite)
Kojima et al. Inhibition of complement‐mediated immune hemolysis by the constant domain of immunoglobulin
ES2183376T3 (es) Uso de lbp para el tratamiento de la septicemia.